A generalized Kiselev crossover approach applied to Soave–Redlich–Kwong equation of state

International audienceThree different variants of the crossover Soave–Redlich–Kwong equation of state are applied to describe the equilibrium behaviour of 72 common non-associating fluids – 27 hydrocarbons (including the first 10 n-alkanes), 36 halogenated refrigerants, 5 cryogenics (fluorine, oxygen, nitrogen, argon and carbon monoxide) and 4 other industrially important inorganic fluids (carbon dioxide, sulfur dioxide, nitrous oxide and sulfur hexafluoride). The model contains six compound dependent parameters.Two of them (a0 and b of the classical part) are adjusted on the critical experimental temperature and the critical pressure. In a first model denoted as model A, the four remaining parameters are fitted to describe the saturated liquid and vapour densities and vapor pressures as well as PVT data at pressures up to P = 3 × Pc. In the second model (model B), the dispersion softness m is expressed as a function of the acentric factor ω and a relation between two of the crossover parameters is employed; the number of fitted parameters is thus reduced to two. Based on model B, we suggested our final Model C, in which all the parameters can be determined from the critical point, acentric factor or rectlinear diameter. This model is superior to the classical Soave–Redlich–Kwong equation of state because it improves considerably the description of the liquid densities over the whole coexistence region. Contrary to equations of state optimized to reproduce the liquid densities at low temperatures, the crossover equation does not overpredict the critical temperature and pressure. Model C is applied to describe the equilibrium behaviour of two compounds not included in the parameterization, hexafluoropropene (HFO1216) and hexafluoropropene oxide (HFPO)

Fast pyrolysis of Miscanthus x Giganteus in an IR heated reactor

International audienceIntensive research on Miscanthus x Giganteus (MG), a large perennial grass, has been achieved in the last ten years because of its known advantages for farmers (high yield, low input, perennial crop, easy harvesting…) [refs 1,2,3,4]. MG is often considered as a good candidate to produce renewable energy. As lignocellulosic feedstock, MG could also serve to produce chemicals. This approach is far less present in the literature. Because logistics costs could affect the attractiveness of MG, pyrolysis is an interesting technology for energy densification [ref 4]. Therefore the present work describes the pyrolysis of Miscanthus x Giganteus. It is well know that pyrolysis products are solids, liquids and gas. Low residence time, enhanced by high heating rates and high flow rates, favors the production of liquids. A temperature range between 450 and 550°C is also recommended to limit gas formation. A new pyrolysis apparatus designed to achieve fast pyrolysis via infrared heating and low residence time is described. Process conditions are varied for temperature, particle size, N 2 flow rate and preheating effect. Pyrolysis temperature should be the most influential parameter upon the yield and properties of bio-oil. Tests are performed at different levels of power and duration. Temperature is measured in the border and in the center of the reactor because of the presence of radial gradients. The highest bio-oil yield and corresponding temperature profiles are presented. The effect of process conditions on bio-oil yield is assessed. The bio-oil composition is analyzed by GCMS. The results are compared with a direct analysis of MG by Py-GCMS. The bio char is characterized in terms of calorific value with respect to the raw MG High Heating Value (HHV). Furthermore, on the one hand the outlet gas composition is analyzed by online infrared spectroscopy which gives an indication of potential use as secondary source of energy. On the other hand the porosity of the bio-solid products is estimated by BET low-temperature adsorption method for further valorization purpose of pyrolysis products. Highlights: 1) New experimental results on Miscanthus x Giganteus pyrolysis are presented. 2) Characterization of every product thus resource potential is evaluated. 3) Comparison of Py-GCMS with lab scale pyrolysis of MG is performed. References: 1) Anissa Khelfa, Victor Sharypov, Gisèle Finqueneisel, Jean Victor Weber J. Anal. Appl. Pyrolysis 84 (2009) 84–88, Catalytic pyrolysis and gasification of Miscanthus Giganteus: Haematite (Fe2O3) a versatile catalyst

Biomolecules from olive pruning waste in Sierra Mágina - Engaging the energy transition by multi-actor and multidisciplinary analyses

Unidad de excelencia María de Maeztu MdM-2015-0552The price volatility of fossil resources, the uncertainty of their long-term availability and the environmental, climatic and societal problems posed by their operation lead to the need of an energy transition enabling the development and utilization of other alternative and sustainable resources. Acknowledging that indirect land-use change can increase greenhouse gas emission, the European Union (EU) has reshaped its biofuel policy. It has set criteria for sustainability to ensure that the use of biofuels guarantees real carbon savings and protects biodiversity. From a sustainability perspective, biofuels and bioliquids offer indeed both advantages (e.g., more secure energy supply, emission reductions, reduced air pollution and production of high added-value molecules) as well as risks (monocultures, reduced biodiversity and even higher emissions through land use change). Approaching economic, environmental and social sustainability at the local level and in an integrated way should help to maximize benefits and minimize risks. This approach has been adopted and is described in the present work that combines chemical, biological, social and territorial studies on the management of pruning waste residues from olive trees in the Sierra Mágina in Spain. The biological and social analyses helped to orientate the research towards an attractive chemical process based on extraction and pyrolysis, in which high added value molecules are recovered and in which the residual biochar may be used as pathogen-free fertilizer. In this region where farmers face declining economic margins, the new intended method may both solve greenhouse gas emission problems and provide farmers with additional revenues and convenient fertilizers. Further research with a larger partnership will consolidate the results and tackle issues such as the logistics

Phase 1 Study of a Combination AMA1 Blood Stage Malaria Vaccine in Malian Children

Apical Membrane Antigen-1 (AMA1) is one of the leading blood stage malaria vaccine candidates. AMA1-C1/Alhydrogel consists of an equal mixture of recombinant AMA1 from FVO and 3D7 clones of P. falciparum, adsorbed onto Alhydrogel. A Phase 1 study in semi-immune adults in Mali showed that the vaccine was safe and immunogenic, with higher antibody responses in those who received the 80 microg dose. The aim of this study was to assess the safety and immunogenicity of this vaccine in young children in a malaria endemic area.This was a Phase 1 dose escalating study in 36 healthy children aged 2-3 years started in March 2006 in Donéguébougou, Mali. Eighteen children in the first cohort were randomized 2 ratio 1 to receive either 20 microg AMA1-C1/Alhydrogel or Haemophilus influenzae type b Hiberix vaccine. Two weeks later 18 children in the second cohort were randomized 2 ratio 1 to receive either 80 microg AMA1-C1/Alhydrogel or Haemophilus influenzae type b Hiberix vaccine. Vaccinations were administered on Days 0 and 28 and participants were examined on Days 1, 2, 3, 7, and 14 after vaccination and then about every two months. Results to Day 154 are reported in this manuscript.Of 36 volunteers enrolled, 33 received both vaccinations. There were 9 adverse events related to the vaccination in subjects who received AMA1-C1 vaccine and 7 in those who received Hiberix. All were mild to moderate. No vaccine-related serious or grade 3 adverse events were observed. There was no increase in adverse events with increasing dose of vaccine or number of immunizations. In subjects who received the test vaccine, antibodies to AMA1 increased on Day 14 and peaked at Day 42, with changes from baseline significantly different from subjects who received control vaccine.AMA-C1 vaccine is well tolerated and immunogenic in children in this endemic area although the antibody response was short lived.Clinicaltrials.gov NCT00341250

Pregnancy outcomes in a malaria-exposed Malian cohort of women of child-bearing age

In Sub-Saharan Africa, malaria continues to be associated with adverse pregnancy outcomes including stillbirth, early neonatal death, preterm delivery, and low birth weight. Current preventive measures are insufficient and new interventions are urgently needed. However, before such interventions can be tested in pregnant women, background information on pregnancy outcomes in this target population must be collected. We conducted an observational study in Ouélessébougou, Mali, a malaria-endemic area where first antenatal visit commonly occurs during the second trimester of pregnancy, hindering calculation of miscarriage rate in the population. To accurately determine the rate of miscarriage, 799 non-pregnant women of child-bearing age were enrolled and surveyed via monthly follow up visits that included pregnancy tests. Out of 505 women that completed the study, 364 became pregnant and 358 pregnancies were analyzed: 43 (12%) resulted in miscarriage, 28 (65.1%) occurred during the first trimester of pregnancy. We also determined rates of stillbirth, neonatal death, preterm delivery, and small for gestational age. The results showed high rate of miscarriage during the first trimester and established a basis to evaluate new interventions to prevent pregnancy malaria. This survey design enabled identification of first trimester miscarriages that are often missed by studies conducted in antenatal clinics.Clinical trial registration[https://clinicaltrials.gov/], identifier [NCT0297 4608]

Dynamics of antigenemia and transmission intensity of Wuchereria bancrofti following cessation of mass drug administration in a formerly highly endemic region of Mali

Background After seven annual rounds of mass drug administration (MDA) in six Malian villages highly endemic for Wuchereria bancrofti (overall prevalence rate of 42.7%), treatment was discontinued in 2008. Surveillance was performed over the ensuing 5 years to detect recrudescence. Methods Circulating filarial antigen (CFA) was measured using immunochromatographic card tests (ICT) and Og4C3 ELISA in 6–7 year-olds. Antibody to the W. bancrofti infective larval stage (L3) antigen, Wb123, was tested in the same population in 2012. Microfilaraemia was assessed in ICT-positive subjects. Anopheles gambiae complex specimens were collected monthly using human landing catch (HLC) and pyrethrum spray catch (PSC). Anopheles gambiae complex infection with W. bancrofti was determined by dissection and reverse transcriptase polymerase chain reaction (RT-PCR) of mosquito pools. Results Annual CFA prevalence rates using ICT in children increased over time from 0% (0/289) in 2009 to 2.7% (8/301) in 2011, 3.9% (11/285) in 2012 and 4.5% (14/309) in 2013 (trend χ 2  = 11.85, df =3, P = 0.0006). Wb123 antibody positivity rates in 2013 were similar to the CFA prevalence by ELISA (5/285). Although two W. bancrofti-infected Anopheles were observed by dissection among 12,951 mosquitoes collected by HLC, none had L3 larvae when tested by L3-specific RT-PCR. No positive pools were detected among the mosquitoes collected by pyrethrum spray catch. Whereas ICT in 6–7 year-olds was the major surveillance tool, ICT positivity was also assessed in older children and adults (8–65 years old). CFA prevalence decreased in this group from 4.9% (39/800) to 3.5% (28/795) and 2.8% (50/1,812) in 2009, 2011 and 2012, respectively (trend χ 2  = 7.361, df =2, P = 0.0067). Some ICT-positive individuals were microfilaraemic in 2009 [2.6% (1/39)] and 2011 [8.3% (3/36)], but none were positive in 2012 or 2013. Conclusion Although ICT rates in children increased over the 5-year surveillance period, the decrease in ICT prevalence in the older group suggests a reduction in transmission intensity. This was consistent with the failure to detect infective mosquitoes or microfilaraemia. The threshold of ICT positivity in children may need to be re-assessed and other adjunct surveillance tools considered

Pre-hospital risk factors for inpatient death from severe febrile illness in Malian children.

BACKGROUND: Inpatient case fatality from severe malaria remains high in much of sub-Saharan Africa. The majority of these deaths occur within 24 hours of admission, suggesting that pre-hospital management may have an impact on the risk of case fatality. METHODS: Prospective cohort study, including questionnaire about pre-hospital treatment, of all 437 patients admitted with severe febrile illness (presumed to be severe malaria) to the paediatric ward in Sikasso Regional Hospital, Mali, in a two-month period. FINDINGS: The case fatality rate was 17.4%. Coma, hypoglycaemia and respiratory distress at admission were associated with significantly higher mortality. In multiple logistic regression models and in a survival analysis to examine pre-admission risk factors for case fatality, the only consistent and significant risk factor was sex. Girls were twice as likely to die as boys (AOR 2.00, 95% CI 1.08-3.70). There was a wide variety of pre-hospital treatments used, both modern and traditional. None had a consistent impact on the risk of death across different analyses. Reported use of traditional treatments was not associated with post-admission outcome. INTERPRETATION: Aside from well-recognised markers of severity, the main risk factor for death in this study was female sex, but this study cannot determine the reason why. Differences in pre-hospital treatments were not associated with case fatality

Impact of a Plasmodium falciparum AMA1 Vaccine on Antibody Responses in Adult Malians

Apical Membrane Antigen 1 (AMA1) of Plasmodium falciparum merozoites is a leading blood-stage malaria vaccine candidate. Protection of Aotus monkeys after vaccination with AMA1 correlates with antibody responses.A randomized, controlled, double-blind phase 1 clinical trial was conducted in 54 healthy Malian adults living in an area of intense seasonal malaria transmission to assess the safety and immunogenicity of the AMA1-C1 malaria vaccine. AMA1-C1 contains an equal mixture of yeast-expressed recombinant proteins based on sequences from the FVO and 3D7 clones of P. falciparum, adsorbed on Alhydrogel. The control vaccine was the hepatitis B vaccine (Recombivax). Participants were enrolled into 1 of 3 dose cohorts (n = 18 per cohort) and randomized 2:1 to receive either AMA1-C1 or Recombivax. Participants in the first, second, and third cohorts randomized to receive AMA1-C1 were vaccinated with 5, 20 and 80 microg of AMA1-C1, respectively. Vaccinations were administered on days 0, 28, and 360, and participants were followed until 6 months after the final vaccination. AMA1-C1 was well tolerated; no vaccine-related severe or serious adverse events were observed. AMA1 antibody responses to the 80 microg dose increased rapidly from baseline levels by days 14 and 28 after the first vaccination and continued to increase after the second vaccination. After a peak 14 days following the second vaccination, antibody levels decreased to baseline levels one year later at the time of the third vaccination that induced little or no increase in antibody levels.Although the AMA1-C1 vaccine candidate was well-tolerated and induced antibody responses to both vaccine and non-vaccine alleles, the antibody response after a third dose given at one year was lower than the response to the initial vaccinations. Additionally, post-vaccination increases in anti-AMA1 antibody levels were not associated with significant changes in in vitro growth inhibition of P. falciparum.ClinicalTrials.gov NCT00343005

Seasonal Climate Effects Anemotaxis in Newly Emerged Adult Anopheles gambiae Giles in Mali, West Africa

The direction and magnitude of movement by the malaria vector Anopheles gambiae Giles has been of great interest to medical entomologists for over 70 years. This direction of movement is likely to be affected by many factors, from environmental conditions and stage of life history of the mosquito to the existence of attractants in the vicinity. We report here the direction of movement of newly emerged An. gambiae in nature, around the village of Donéguébougou, Mali. We assessed the direction of movement for individual mosquitoes by placing them in a novel enclosure with exit traps oriented in the direction of the cardinal and intermediate points of the compass. We consistently found predominantly Southward directions of movement during 2009 and 2010, with an additional Eastward component during the dry season and a Westward one during the wet season. Our data indicate that wind has an important effect on the direction of movement, but that this effect varied by season: Average directions of movement were downwind during the dry season and upwind during the wet season. A switch in anemotactic response suggests that the direction of movement of An. gambiae relative to the wind immediately after emergence under varying conditions of humidity should be further investigated under controlled conditions